KRAS and lung adenocarcinoma: Recent studies of TCGA data in EGFR-mut, KRAS-mut, and wild-type (no known driver mutations) (WT) lung adenocarcinomas, confirmed this prediction as few genes were found to be conserved even among subtypes that shared a common tissue of origin (Freischel et al., 2021).